logo
Share SHARE
FONT-SIZE Plus   Neg

BTG Reports Positive Results From Second US Pivotal Phase III Trial Of Varisolve

BTG Plc (BGC.L) announced the successful outcome of VANISH-1, the second and final US pivotal Phase III trial of Varisolve (polidocanol endovenous microfoam (PEM)) as a potential treatment for patients with saphenofemoral junction incompetence and symptomatic and/or visible varicose veins. All end points were met with all active PEM concentrations with a high degree of statistical significance, the company said.

Patients treated with PEM showed a statistically significant improvement in symptoms, the primary endpoint, versus patients who received placebo. The co-secondary endpoints of improvement in appearance in PEM-treated patients compared with patients who received placebo, as measured by both a patient-reported outcome and by a blinded independent panel review of photographs, were also met.

In addition, the three tertiary endpoints, response to treatment as determined by duplex ultrasound, change in the Venous Clinical Severity Score and Quality of Life as measured by the modified VEINES-QOL/Sym questionnaire, were all statistically significantly better for patients treated with PEM compared to patients who received placebo.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Food delivery startup DoorDash and courier service Postmates have joined with robotic delivery developer Starship Technologies for conducting commercial delivery trials over the next few weeks. With Starship's self-driving delivery robots, DoorDash will do the delivery tests in Redwood City, California, while Postmates' tests will take place in Washington, D.C. They will carry food orders ... Aiming to better prepare its employees, Delta Air Lines has decided to begin new diversity training for all of its flight crews after incidents of alleged discrimination against passengers, Bloomberg reported. *** is the stock in focus, on the merit of its valuation and upbeat guidance revision. The company ***, a vendor of fiber-optic components, revised up fourth-quarter revenue guidance above Street estimates. We think the stock has at least 10% upside from current levels.
comments powered by Disqus
Follow RTT